Editorials

JAK inhibitors and myelofibrosis, Einstein and ruxolitinib

Department of Hematology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Vol. 100 No. 4 (2015): April, 2015 https://doi.org/10.3324/haematol.2015.124099